Interestingly, serum adropin levels in psoriatic patients with metabolic syndrome were significantly lower compared to those without metabolic syndrome, although all patients suffering from psoriasis have lower serum adropin levels compared to the healthy controls. This evidence concerns the gene ENHO and metabolic syndrome.